|
LONRF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.4298999995741E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.943300E-03 |
| Normal-vs-Stage2 |
1.063700E-02 |
| Normal-vs-Stage3 |
3.64039998146382E-09 |
| Normal-vs-Stage4 |
2.400300E-04 |
| Stage1-vs-Stage2 |
8.831800E-01 |
| Stage1-vs-Stage3 |
3.577600E-01 |
| Stage1-vs-Stage4 |
6.983400E-01 |
| Stage2-vs-Stage3 |
5.538800E-01 |
| Stage2-vs-Stage4 |
8.508000E-01 |
| Stage3-vs-Stage4 |
5.723200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.21350000000542E-05 |
| Normal-vs-AfricanAmerican |
9.06350000051681E-07 |
| Normal-vs-Asian |
1.004150E-03 |
| Caucasian-vs-AfricanAmerican |
8.803200E-01 |
| Caucasian-vs-Asian |
5.699600E-01 |
| AfricanAmerican-vs-Asian |
7.598000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
7.572000E-01 |
| Male-vs-Female |
2.454500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.965090E-04 |
| Normal-vs-Extreme_Weight |
4.935800E-02 |
| Normal-vs-Obese |
1.67843999999695E-05 |
| Normal-vs-Extreme_Obese |
2.3513000435571E-09 |
| Normal_Weight-vs-Extreme_Weight |
9.905200E-01 |
| Normal_Weight-vs-Obese |
8.930600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.207800E-02 |
| Extreme_Weight-vs-Obese |
9.540200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.530000E-01 |
| Obese-vs-Extreme_Obese |
1.454110E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.976530E-03 |
| Normal-vs-Age(41-60Yrs) |
3.076200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.38779987501891E-10 |
| Normal-vs-Age(81-100Yrs) |
5.77709999949327E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.213600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.869990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.472240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.731750E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.360580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.761600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.9243051596618E-11 |
| Normal-VS-Type2 PRCC |
2.56619999694507E-08 |
| Normal-VS-KIRP CIMP |
5.100400E-02 |
| Normal-VS-Unclassified PRCC |
1.97413999999396E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.858200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.846000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.711800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.863000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.574600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.723200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.36684022275813E-12 |
| Normal-vs-N1 |
5.258900E-03 |
| Normal-vs-N2 |
2.233700E-02 |
| N0-vs-N1 |
2.018300E-02 |
| N0-vs-N2 |
9.391700E-02 |
| N1-vs-N2 |
7.669400E-01 |
|
|
